Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination Antifungal Therapy for Candida Bloodstream Infections
PACTR202609774120990Phase 3Not yet recruiting
- Sponsor
- Wits Health Consortium
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of micafungin and flucytosine in candidemia (4 arms), sponsored by Wits Health Consortium. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
micafunginflucytosine
03
Conditions
candidemia
Beyond the preview
Go deeper on PACTR202609774120990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202609774120990.